Fragmented Care Does Not Affect Survival Outcomes for Retroperitoneal Sarcoma, Fox Chase Cancer Center Study Finds
In a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and treatment and traveled farther to receive treatment, but their overall survival rates were equivalent to patients receiving nonfragmented care.